Arrayit: Microarray Technology for Life Sciences Research

Arrayit Corporation is a life sciences company specializing in microarray-based tools, instrumentation, and diagnostic platforms for genomic and proteomic research. The company serves over 10,000 research laboratories, pharmaceutical companies, academic institutions, and biotechnology companies globally, providing patented microarray manufacturing platforms and genotyping technologies. Arrayit products enable scientists to measure gene expression, detect genetic variants, quantify antibody levels, and miniaturize laboratory procedures through contact printing technology applicable to every living organism. Founded to advance microarray applications in biomedicine and agriculture, Arrayit has established itself as a provider of precision instruments and consumables for high-throughput genomic analysis.read more

Arrayit’s microarray platforms leverage glass slides, fluorescence detection, robotics, and computer automation to accelerate data acquisition in life sciences research. The company’s proprietary contact printing technology and manufacturing approaches deliver ultra-high tolerance for exacting applications. Research applications span cancer biomarker discovery, autoantibody detection for disease diagnostics, pathogen identification, and gene expression and protein profiling.

Key application areas include:

  • Cancer diagnostics and recurrence monitoring (breast, ovarian, lung, bladder cancer)
  • Autoantibody-based blood testing for disease detection
  • Gene expression analysis and transcription factor studies
  • Pathogen detection and infectious disease research
  • Agricultural genomics and crop plant improvement
  • Antibody profiling and immunological research

The company’s technology portfolio addresses critical needs in translational research, enabling scientists to transition from basic discovery to clinical diagnostic development. Arrayit microarray scanners accommodate various slide formats and detection requirements, supporting both academic research and clinical laboratory workflows.

Why Choose Arrayit Products?

Arrayit microarray systems have been validated in numerous peer-reviewed publications addressing clinical challenges in oncology diagnostics. The company’s technology has demonstrated capability in identifying tumor-associated antigens and developing multi-parameter biomarker panels that outperform single-marker approaches, with some achieving AUC values of 0.91 in bladder cancer recurrence studies. This evidence-based performance provides researchers with confidence in data quality for biomarker discovery projects.

The company’s Professional Series Technology incorporates proprietary materials and manufacturing processes designed for researchers requiring precise, reproducible results. Arrayit microarray systems accommodate small hybridization volumes (as low as 2 microliters) while maintaining sensitivity for rare transcript detection from minimal sample input. This miniaturization capability reduces reagent costs and enables analysis of precious biological samples.

Nearly every major research center worldwide utilizes Arrayit products for genomic exploration across human, plant, and animal species. Technology supports discoveries in biomedicine and agriculture, contributing to novel gene function insights, early-stage disease diagnostics, pharmaceutical safety improvements, and enhanced crop nutrition. Arrayit’s VIP™ genotyping technology and patented microarray manufacturing platform provide researchers with tools that have enabled publications on autoantibody signatures, differential gene expression measurements, and high-throughput antigen screening.

read less

Fitlers
Category